Clinical Trials on Ureteropelvic Junction Obstruction in United Kingdom

Total 5346 results

GlaxoSmithKline

Completed

Blood Levels and Effects of GSK1325756 in Healthy Adult Volunteers Aged 40 to 80 Years Old

Pulmonary Disease, Chronic Obstructive

United Kingdom
AstraZeneca
RTI Health Solutions

Recruiting

Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular Endpoints (PASS)

Pulmonary Disease, Chronic Obstructive

United Kingdom
Theravance Biopharma
GlaxoSmithKline

Completed

Succinate Salt Version of GSK961081 for Healthy Volunteers

Pulmonary Disease, Chronic Obstructive

United Kingdom
AstraZeneca

Completed

A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

Study To Examine Safety, Tolerability And Pharmacokinetics Of Intravenous Doses And Oral Dose Of GSK233705

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

To Assess the Excretion Balance and Pharmacokinetics of a Single Oral Dose of [14C]GW856553 in Healthy Adult Males

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

A Study To Evaluate The Safety And Tolerability Of SB-656933-AAA Following Repeated Doses In Healthy Adult Subjects

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

First Time in Human Study With GSK1325756

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

Pharmacokinetic and Safety of GSK573719 and GW642444 Administered Individually and Concurrently, With Verapamilin in Healthy Subjects

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

A Study to Look at How GSK1325756 is Taken up by the Body When Given by Mouth When Stomach Acid is Reduced

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline
ICON plc

Completed

FF/UMEC/VI Inhaler: Qualitative Analysis and Subject Preference Survey

Pulmonary Disease, Chronic Obstructive

United Kingdom
Imperial College London
Boehringer Ingelheim

Completed

Airway Effects of Tiotropium in Patients With COPD

COPD | LUNG DISEASES, OBSTRUCTIVE

United Kingdom
GlaxoSmithKline

Completed

Optimising the Propranolol Block Model

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of the Dry Powder Formulation of GSK2269557 in Healthy Subjects

Pulmonary Disease, Chronic Obstructive

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Study to Investigate the Effect of Formoterol vs Salmeterol on Small Airways Physiological Parameters in COPD Patients (Imperial)

Pulmonary Disease, Chronic Obstructive

United Kingdom
London School of Hygiene and Tropical Medicine
University College, London; British Medical Research Council

Completed

Survival After First Myocardial Infarction in Patients With and Without Chronic Obstructive Pulmonary Disease

Myocardial Infarction | Chronic Obstructive Pulmonary Disease

United Kingdom
The Royal Wolverhampton Hospitals NHS Trust

Withdrawn

Cricothyroidotomy Training for Physicians Outcomes Study

Airway Obstruction

United Kingdom
GlaxoSmithKline

Not yet recruiting

A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive

United Kingdom
Angion Biomedica Corp
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Unknown

Study on Delayed Graft Function Using Paired Kidneys

Delayed Graft Function

Netherlands, Spain, United Kingdom
Royal Brompton & Harefield NHS Foundation Trust

Unknown

The Effect of Two Weeks of Voluntary Reduced Physical Activity in Chronic Obstructive Pulmonary Disease (COPD)

Muscle Atrophy | Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
Wellspect HealthCare

Completed

The Value of Multiple Urine Flow Rate Measurements in Male Benign Prostatic Hyperplasia (BPH) Subjects

Lower Urinary Tract Symptoms | Bladder Outlet Obstruction

United States, Netherlands, Poland, United Kingdom
Cook Group Incorporated

Completed

Evaluation of the Zilver® Vena™ Venous Stent (VIVO EU)

Iliofemoral Venous Outflow Obstruction

Switzerland, United Kingdom, Ireland, Germany, Spain
Tetherex Pharmaceuticals Corporation

Completed

Study to Assess the Safety and Efficacy of SelK2 on Airway Responses Following Allergen Challenge in Subjects With Asthma (Part 1) and in Subjects With Chronic Obstructive Pulmonary Disease (Part 2)

Chronic Obstructive Pulmonary Disease | Asthma

United Kingdom
Manchester University NHS Foundation Trust

Completed

Cough Responses to Tussive Agents in Health and Disease

Asthma | Chronic Cough | Chronic Obstructive Airway Disease

United Kingdom
Hull University Teaching Hospitals NHS Trust
Galen Limited

Withdrawn

Erdosteine (Erdotin) Versus Standard Care Plus Placebo on Erdosteine for Treatment of Cough in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

United Kingdom
Cambridge University Hospitals NHS Foundation Trust
GlaxoSmithKline; University of Cambridge; Royal Brompton & Harefield NHS Foundation... and other collaborators

Completed

Losmapimod in Chronic Obstructive Pulmonary Disease Patients Stratified by Fibrinogen. (EVOLUTION)

Chronic Obstructive Pulmonary Disease

United Kingdom
Amazentis SA
University of Washington; Synteract, Inc.

Completed

Bioenergetics and Muscle Function Improvement With AMAZ-02 in Elderly Skeletal Muscle (ENERGIZE Trial)

Aging | Muscle Function | Mitochondrial Function, Bioenergetics

United States
Columbia University
National Institute on Aging (NIA)

Terminated

Cognitive Control and Physical Exercise

Cognitive Function | Day-to-Day Function

United States
Royal Brompton & Harefield NHS Foundation Trust
Imperial College London

Unknown

Lung Volume Reduction Coil Microbiome Study (LVRC-Micro)

Chronic Obstructive Pulmonary Disease | Emphysema

United Kingdom
my mhealth Ltd
University of Southampton; University Hospitals Bristol and Weston NHS Foundation... and other collaborators

Recruiting

A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD (PROPEL myCOPD)

Chronic Obstructive Pulmonary Disease

United Kingdom
Mayo Clinic
Ethicon Endo-Surgery

Completed

Dynamic MRI Evaluation Post Operative Stapled Trans Anal Rectal Resection (STARR) Procedure

Obstructive Defecation Syndrome | Outlet Obstruction

United States
AstraZeneca

Completed

Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPD

Asthma | Chronic Obstructive Pulmonary Disease (COPD)

United Kingdom
University of Nottingham
AstraZeneca

Recruiting

Clinic Versus Home Spirometry (COMPAIR)

Chronic Obstructive Pulmonary Disease | Asthma

United Kingdom
GlaxoSmithKline

Completed

Helium-3 MRI Imaging Study in COPD

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline
Hammersmith Medicines Research

Completed

GSK961081 Alone and With Fluticasone Furoate (FF), Phase 1 (Ph1), Single Dose Regimen (SD), Repeat Dose Regimen (RD), Pharmacokinetic (PK) Study in Healthy Volunteer (HV)

Pulmonary Disease, Chronic Obstructive

United Kingdom
University of Dundee
NHS Tayside; NHS Fife; Chief Scientist Office of the Scottish Government

Completed

Do Phosphodiesterase 5A Inhibitors Improve Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Pulmonary Hypertension?

Chronic Obstructive Pulmonary Disease | Pulmonary Hypertension

United Kingdom
Patrick Murphy
ResMed; ResMed Foundation; Guy's & St Thomas' Charity; Respironics International

Completed

Home Mechanical Ventilation vs Home Oxygen Therapy in COPD

Chronic Obstructive Pulmonary Disease

United Kingdom
Queen Mary University of London
GlaxoSmithKline; British Lung Foundation

Completed

Withdrawal of Inhaled Corticosteroids in Patients With COPD in Primary Care

Chronic Obstructive Pulmonary Disease

United Kingdom
Life Detection Technologies
Royal Free Hospital NHS Foundation Trust

Not yet recruiting

Non-contact Proactive Remote Monitoring of COPD Exacerbations (DetectEx)

COPD Exacerbation

United Kingdom
Imperial College London

Recruiting

The London COPD Exacerbation Cohort (EXCEL_Cohort)

Pulmonary Disease, Chronic Obstructive

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

BDP/FF Versus Formoterol Fumarate (FF) in Patients With Severe COPD (Lung Function and Exacerbation Rate)

Pulmonary Disease, Chronic Obstructive

United Kingdom
University Hospital Birmingham NHS Foundation Trust
University of Birmingham; Dystrophic Epidermolysis Bullosa Research Association...

Enrolling by invitation

Genotype-phenotype Correlation in Junctional Epidermolysis Bullosa

Junctional Epidermolysis Bullosa | Laryngo Onycho Cutaneous Syndrome

United Kingdom
Breathe Technologies, Inc.

Completed

Non-invasive Ventilation System in Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) (PRIDE)

Pulmonary Disease, Chronic Obstructive | Chronic Obstructive Lung Disease | Chronic Obstructive Airway Disease | Airflow Obstruction, Chronic

United States
Northumbria Healthcare NHS Foundation Trust
Newcastle-upon-Tyne Hospitals NHS Trust

Recruiting

Influence of Reliance on Historical Blood Eosinophil Counts on ICS Prescribing by GOLD 2019 Thresholds in COPD (BECCOPD)

Chronic Obstructive Pulmonary Disease

United Kingdom
University of Birmingham
Salford Royal Foundation Trust

Recruiting

Sputum Colour Charts to Guide Antibiotic Self-treatment of Acute Exacerbation of COPD (Colour COPD)

Pulmonary Disease, Chronic Obstructive

United Kingdom
Theravance Biopharma
GlaxoSmithKline

Completed

Study of GSK961081 in Healthy Volunteer Subjects

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy Subjects

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects.

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

Absorption & Elimination of Radiolabelled GSK2269557

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

GSK573719 IV Enabling Study

Pulmonary Disease, Chronic Obstructive

United Kingdom

Clinical Trials on Ureteropelvic Junction Obstruction in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations